Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 October 2019 | Story Ngang Carol | Photo Stephen Collett
International conference delegates
International delegates attending the International Conference on the Right to Development hosted on the Bloemfontein Campus.

The International Conference on the Right to Development was held in Bloemfontein for the first time from 25 to 27 September 2019, hosted by the Free State Centre for Human Rights at the University of the Free State. This is the third in the international conference series launched in 2017 with the aim of advancing the right to development both in Africa and internationally. This year’s conference follows the previous two that were held at the Centre for Human Rights, University of Pretoria, in September 2017 and August 2018.  

Based on the theme, ‘The right to development and natural resource ownership’, the 3rd International Conference on the Right to Development offered the forum and opportunity to participants from a diversity of backgrounds and disciplines to interact and share knowledge on their research outputs, which extensively explored questions on how natural resource ownership could contribute to the realisation of the right to development. The keynote address was delivered by Prof John C Mubangizi, Dean of the Faculty of Law at the University of the Free State. 

The three-day conference registered a total of 35 participants and 27 presentations out of the 33 that were scheduled. Participants came from different countries, including South Africa, Botswana, Zimbabwe, the Democratic Republic of the Congo, Cameroon, Nigeria, Ghana, Kenya, Uganda, Ethiopia, and the United Kingdom. Some of those who were unable to attend had the opportunity to present their papers through Skype. The presentations stimulated exciting and robust debates. 

The International Conference Series on the Right to Development is jointly organised and co-sponsored by the Centre for Human Rights, University of Pretoria; the Thabo Mbeki African Leadership Institute, University of South Africa; and the Free State Centre for Human Rights, University of the Free Sate. In its three years of existence, it has progressively established a steady track record of publications, including journal articles in special editions of selected journals and collections of chapters in edited volumes. 

The next (fourth) conference is intended to be much bigger and is scheduled to take place in Kigali, Rwanda, in 2021. 

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept